treatment

Maximilian Stahl, MD

Institution
Yale University School of Medicine
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)

Advances in the Treatment Paradigm of Myeloid Malignancies: From Biology to Clinical Practice

Thumbnail for video Watch Now

Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Uma Borate, MBBS
Sudipto Mukherjee, MD, MPH
Abhay Singh, MD, MPH
This complimentary CME satellite symposium provided an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with AA, PNH, MDS, AML, MPN, and related myeloid malignancies. The overall goal of the…

Iptacopan

FABHALTA, a complement factor B inhibitor, is the first oral medication approved to treat adults with

Lisa: Finding the Light

Lisa loved her work.
As a Senior Teacher in the UK, she dedicated herself, her time, and her passion to her job.  An average week saw her working 70 hours.
Following a beach holiday in the Canary Islands, she developed a strange rash on the top of her feet. A colleague urged her to go to the doctor.

AAMDSIF 40th Anniversary Summit

Thumbnail for video Watch Now

Topic(s)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Since it was founded in 1983, AAMDSIF has partnered with clinicians and researchers to identify knowledge gaps in diagnosing and treating bone marrow failure and the research priorities needed to advance the field. In honor of the AAMDSIF 40th Anniversary, this hybrid Summit will…

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.